UnitedHealth Group Incorporated $UNH Shares Purchased by BIP Wealth LLC

BIP Wealth LLC increased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 237.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,065 shares of the healthcare conglomerate’s stock after acquiring an additional 2,158 shares during the quarter. BIP Wealth LLC’s holdings in UnitedHealth Group were worth $1,012,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of UNH. Capital Research Global Investors increased its stake in UnitedHealth Group by 126.9% in the third quarter. Capital Research Global Investors now owns 13,042,049 shares of the healthcare conglomerate’s stock valued at $4,503,419,000 after purchasing an additional 7,293,009 shares during the period. Berkshire Hathaway Inc acquired a new position in UnitedHealth Group in the second quarter valued at $1,572,193,000. Capital World Investors increased its stake in UnitedHealth Group by 18.8% in the third quarter. Capital World Investors now owns 21,766,922 shares of the healthcare conglomerate’s stock valued at $7,516,107,000 after purchasing an additional 3,439,182 shares during the period. Capital International Investors boosted its holdings in shares of UnitedHealth Group by 11.1% in the third quarter. Capital International Investors now owns 17,499,949 shares of the healthcare conglomerate’s stock valued at $6,042,710,000 after acquiring an additional 1,747,337 shares in the last quarter. Finally, Lone Pine Capital LLC purchased a new stake in shares of UnitedHealth Group in the second quarter valued at about $528,273,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Stock Performance

UNH opened at $306.29 on Thursday. The stock has a market cap of $278.02 billion, a P/E ratio of 23.22, a P/E/G ratio of 1.28 and a beta of 0.40. The company has a debt-to-equity ratio of 0.72, a current ratio of 0.79 and a quick ratio of 0.79. The stock’s 50 day simple moving average is $282.36 and its 200 day simple moving average is $318.95. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $606.36.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, January 27th. The healthcare conglomerate reported $2.11 earnings per share for the quarter, topping analysts’ consensus estimates of $2.09 by $0.02. The business had revenue of $113.73 billion for the quarter, compared to analysts’ expectations of $113.38 billion. UnitedHealth Group had a return on equity of 14.79% and a net margin of 2.69%.The company’s revenue was up 12.3% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $6.81 EPS. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. As a group, equities analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 17th. Shareholders of record on Monday, March 9th were given a dividend of $2.21 per share. The ex-dividend date was Monday, March 9th. This represents a $8.84 dividend on an annualized basis and a yield of 2.9%. UnitedHealth Group’s payout ratio is presently 67.02%.

Analyst Ratings Changes

UNH has been the topic of several analyst reports. Truist Financial lowered their target price on shares of UnitedHealth Group from $410.00 to $370.00 and set a “buy” rating on the stock in a report on Monday, February 2nd. Evercore raised shares of UnitedHealth Group to a “strong-buy” rating in a report on Tuesday, January 6th. Jefferies Financial Group lowered their target price on shares of UnitedHealth Group from $418.00 to $340.00 and set a “buy” rating on the stock in a report on Wednesday, January 28th. Morgan Stanley lowered their target price on shares of UnitedHealth Group from $411.00 to $409.00 and set an “overweight” rating on the stock in a report on Friday, January 23rd. Finally, JPMorgan Chase & Co. decreased their price objective on shares of UnitedHealth Group from $425.00 to $389.00 and set an “overweight” rating on the stock in a report on Monday, February 2nd. One equities research analyst has rated the stock with a Strong Buy rating, eighteen have issued a Buy rating, eight have given a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $363.42.

Key Stories Impacting UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: CMS raised 2027 Medicare Advantage payments by ~2.48%, a surprise above street expectations — this directly improves UnitedHealth’s revenue and margin outlook for Medicare Advantage and triggered a broad relief rally across managed-care names. UnitedHealth Rockets 11%, Humana Climbs 9% as Medicare Advantage Rate Decision Crushes Regulatory Fears
• Positive Sentiment: Several sell-side analysts raised price targets and upgraded UNH after the CMS decision (example: BofA and Sanford C. Bernstein moves), contributing to the near-term re-rating and higher trading volume. UnitedHealth Price Target Raised to $337 by BofA After Medicare Advantage Rate Finalization
• Positive Sentiment: Street research and note-writers are quantifying meaningful upside from the CMS move (several pieces estimate billions in incremental revenue/operating profit and reduced downside risk), which supports expectations for margin recovery driven by UnitedHealth’s scale and Optum capabilities. UnitedHealth Could Reprice Soon: The Catalyst Is Here
• Neutral Sentiment: Wall Street remains broadly constructive on UNH: ~75% of covering analysts rate the stock bullishly with a consensus target around $355, and UNH is highlighted among hedge-fund favorites — that supports medium-term investor interest but already implies some upside is priced in. Analysts Remain Confident in UnitedHealth (UNH)’s Growth Initiatives Outside of Its Main Insurance Operations
• Neutral Sentiment: Recent fundamental context: UnitedHealth beat Q4/most-recent EPS estimates and provided FY-level guidance, which underpinned confidence before the CMS news — but consensus EPS forecasts remain materially higher than some boutique analyst raises. UnitedHealth Stock Jumps on Better-Than-Expected Medicare Advantage Rates. Here’s Why the Rally Might Be Short-Lived
• Negative Sentiment: Caution: commentators warn the Medicare tailwind may be partially priced in after the large one-day rally and the stock faces near-term catalysts (upcoming quarterly results) that could reintroduce volatility if guidance or cost trends disappoint. UnitedHealth Stock Jumps on Better-Than-Expected Medicare Advantage Rates. Here’s Why the Rally Might Be Short-Lived
• Negative Sentiment: Macroeconomic and cost risks remain (medical-cost inflation, optical/claims mix, and broader interest-rate/market moves). Those factors plus profit-taking after the run-up explain why UNH has pulled back from its intraday highs. UnitedHealth (UNH) Soars 9.4%: Is Further Upside Left in the Stock?

UnitedHealth Group Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.